Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Seres Therapeutics, Inc.
High uncertainty: The valuation methods show significant disagreement (>100% spread). Treat the range as a rough guide rather than a precise estimate.
Bear Case (25th pct.)
25.6% vs price
Base Case (Median)
25.6% vs price
Bull Case (75th pct.)
25.6% vs price
| Method | Est. Value | vs Price | Weight |
|---|---|---|---|
| EV/EBITDA | $6.29 | 25.6% | Medium (20%) |
Insufficient data to generate a reliable fair value estimate for MCRB. Try again later or check if this symbol has full financial data.
Bear/base/bull cases represent the 25th, 50th, and 75th percentile of available method estimates. This is not financial advice. Valuation is inherently uncertain.